Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer

• Main Authors: Yuqin Lin (Author), Yanghong Zhu (Author), Xiang Li (Author), Qi Chen (Author), Guoyu Wu (Author)
• Formato: Libro
• Publicado: KeAi Communications Co., Ltd., 2023-12-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Triple-negative breast cancer (TNBC) is a special type of breast cancer in which ER, PR and HER2 are all negative, characterized by high malignancy, strong invasiveness, and high recurrence rate. It is critical to develop novel drugs for improved therapies for triple-negative breast cancers. Here, w...